Blog
RSS FeedPosted by Michael Wonder on 27 Oct 2017
FDA accepts Genentech’s supplemental biologics license application for Avastin as a front-line treatment for women with advanced ovarian cancer
25 October 2017 - Genentech announced today that the U.S. FDA has accepted the company's supplemental biologics license application for ...
Posted by Michael Wonder on 27 Oct 2017
MorphoSys receives FDA breakthrough therapy designation for its antibody MOR208 in relapsed/refractory DLBCL
23 October 2017 - Designation is intended to expedite development of MorphoSys's most advanced blood cancer drug candidate MOR208 in ...
Posted by Michael Wonder on 26 Oct 2017
CVS Health is in talks to buy Aetna
26 October 2017 - Sources say CVS Health has proposed to buy Aetna for more than $200 a share, or $66 ...
Posted by Michael Wonder on 26 Oct 2017
Americans want to see a bipartisan fix for Obamacare: Reuters/Ipsos poll
26 October 2017 - As Republican and Democratic lawmakers clash over the future of Obamacare, Americans largely are eager for a ...
Posted by Michael Wonder on 26 Oct 2017
New shingles vaccine endorsed over competitor by expert panel, a boost for GSK
25 October 2017 - The expert panel that helps guide U.S. vaccination policy has voted to give a preferential recommendation ...
Posted by Michael Wonder on 26 Oct 2017
PTC Therapeutics receives complete response letter for ataluren's NDA
25 October 2017 - PTC Therapeutics today announced that the Office of Drug Evaluation I of the U.S. FDA has ...
Posted by Michael Wonder on 26 Oct 2017
Tesaro announces U.S. FDA approval of Varubi IV for delayed nausea and vomiting associated with cancer chemotherapy
25 October 2017 - Availability of new formulation offers healthcare providers the flexibility to choose oral or IV administration. ...
Posted by Michael Wonder on 25 Oct 2017
Which road to universal coverage?
25 October 2017 - According to a June 2017 poll, Americans agree by a 60-to-39 margin that the federal government bears ...
Posted by Michael Wonder on 25 Oct 2017
How to think about “Medicare for all”
25 October 2017 - In April 1946, President Harry Truman introduced a single-payer health plan and met the same reaction that ...
Posted by Michael Wonder on 25 Oct 2017
Co-pay method helps drive up drug prices
24 October 2017 - One of the biggest mistakes in health-insurance benefit design was to use fixed copayments instead of the ...
Posted by Michael Wonder on 25 Oct 2017
U.S. lawmakers will not tackle healthcare this year, Ryan says
26 October 2017 - Republican lawmakers will not take up a bipartisan plan to stabilise Obamacare insurance markets or try again ...
Posted by Michael Wonder on 25 Oct 2017
Mr. Quixote goes to Washington? A bill would allow Medicare to negotiate drug prices.
25 October 2017 - In what some may call a quixotic move, a group of Democratic lawmakers on Wednesday will ...
Posted by Michael Wonder on 25 Oct 2017
Institute for Clinical and Economic Review opens nominations for new members of its voting panels
26 October 2017 - Independent panel members debate the evidence on the effectiveness and value of new drugs and other health ...
Posted by Michael Wonder on 25 Oct 2017
Medivir receives FDA fast track designation for MIV-711 for the treatment of osteoarthritis
24 October 2017 - Medivir today announced that the U.S. FDA has granted fast track designation for the company´s product ...
Posted by Michael Wonder on 24 Oct 2017
FDA grants fast track designation to Alzheon’s ALZ-801 development program for the treatment of Alzheimer’s disease
24 October 2017 - Company’s phase 3 clinical program pioneers a precision medicine approach in Alzheimer’s disease. ...